First Barcelona Conference on Epigenetics and Cancer

Epigenetics

Volumn 9, Issue 3, 2014, Pages 468-475

  Palau, Anna ^a   Perucho, Manuel ^a,b   Esteller, Manel ^b,c,d   Buschbeck, Marcus ^a  

^a Institute of Predictive and Personalized Medicine of Cancer IMPPC   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Cancer; Chromatin; Differentiation; DNA methylation; Epigenetics; Histone modification; Reprogramming; Stem cells

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; HISTONE DEACETYLASE; HISTONE H1; HISTONE H4; I BET; MICRORNA; MITHRAMYCIN; POLYCOMB GROUP PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; RIBOSOME DNA; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HISTONE MODIFICATION; HUMAN; LEUKEMIA; NEOPLASM; NONHUMAN; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; SCHISTOSOMA MANSONI; STEM CELL;

CANCER; CHROMATIN; DIFFERENTIATION; DNA METHYLATION; EPIGENETICS; HISTONE MODIFICATION; REPROGRAMMING; STEM CELLS;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; NEOPLASMS; REGENERATIVE MEDICINE; STEM CELLS;

EID: 84899148497     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.27759     Document Type: Article

References (49)

1. Bulut-Karslioglu A, Perrera V, Scaranaro M, de la Rosa-Velazquez IA, van de Nobelen S, Shukeir N, Popow J, Gerle B, Opravil S, Pagani M, et al. A transcription factor-based mechanism for mouse heterochromatin formation. Nat Struct Mol Biol 2012; 19:1023-30; PMID:22983563; http://dx.doi. org/10.1038/nsmb.2382
2. Schiza V, Molina-Serrano D, Kyriakou D, Hadjiantoniou A, Kirmizis A. N-alpha-terminal acetylation of histone H4 regulates arginine methylation and ribosomal DNA silencing. PLoS Genet 2013; 9:e1003805; PMID:24068969; http://dx.doi. org/10.1371/journal.pgen.1003805
3. Tessarz P, Santos-Rosa H, Robson SC, Sylvestersen KB, Nelson CJ, Nielsen ML, Kouzarides T. Glutamine methylation in histone H2A is an RNApolymerase-I-dedicated modification. Nature 2014; 505:564-8; PMID:24352239; http://dx.doi. org/10.1038/nature12819
4. Millanes-Romero A, Herranz N, Perrera V, Iturbide A, Loubat-Casanovas J, Gil J, Jenuwein T, García de Herreros A, Peiró S. Regulation of Heterochromatin Transcription by Snail1/LOXL2 during Epithelialto-Mesenchymal Transition. Mol Cell 2013; 52:746-57; PMID:24239292; http://dx.doi.org/10.1016/j. molcel.2013.10.015
5. Herranz N, Dave N, Millanes-Romero A, Morey L, Díaz VM, Lórenz-Fonfría V, Gutierrez-Gallego R, Jerónimo C, Di Croce L, García de Herreros A, et al. Lysyl oxidase-like 2 deaminates lysine 4 in histone H3. Mol Cell 2012; 46:369-76; PMID:22483618; http://dx.doi.org/10.1016/j.molcel.2012.03.002
6. Di Croce L, Helin K. Transcriptional regulation by Polycomb group proteins. Nat Struct Mol Biol 2013; 20:1147-55; PMID:24096405; http://dx.doi. org/10.1038/nsmb.2669
7. Morey L, Pascual G, Cozzuto L, Roma G, Wutz A, Benitah SA, Di Croce L. Nonoverlapping functions of the Polycomb group Cbx family of proteins in embryonic stem cells. Cell Stem Cell 2012; 10:47-62; PMID:22226355; http://dx.doi.org/10.1016/j. stem.2011.12.006
8. Morey L, Aloia L, Cozzuto L, Benitah SA, Di Croce L. RYBP and Cbx7 define specific biological functions of polycomb complexes in mouse embryonic stem cells. Cell Rep 2013; 3:60-9; PMID:23273917; http://dx.doi.org/10.1016/j.celrep.2012.11.026
9. Ballaré C, Lange M, Lapinaite A, Martin GM, Morey L, Pascual G, Liefke R, Simon B, Shi Y, Gozani O, et al. Phf19 links methylated Lys36 of histone H3 to regulation of Polycomb activity. Nat Struct Mol Biol 2012; 19:1257-65; PMID:23104054; http://dx.doi. org/10.1038/nsmb.2434
10. Creppe C, Posavec M, Douet J, Buschbeck M. MacroH2A in stem cells: a story beyond gene repression. Epigenomics 2012; 4:221-7; PMID:22449192; http://dx.doi.org/10.2217/epi.12.8
11. Gamble MJ, Frizzell KM, Yang C, Krishnakumar R, Kraus WL. The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. Genes Dev 2010; 24:21-32; PMID:20008927; http://dx.doi. org/10.1101/gad.1876110
12. Buschbeck M, Uribesalgo I, Wibowo I, Rué P, Martin D, Gutiérrez A, Morey L, Guigó R, López-Schier H, Di Croce L. The histone variant macroH2A is an epigenetic regulator of key developmental genes. Nat Struct Mol Biol 2009; 16:1074-9; PMID:19734898; http://dx.doi.org/10.1038/nsmb.1665
13. Cantariño N, Douet J, Buschbeck M. MacroH2A--an epigenetic regulator of cancer. Cancer Lett 2013; 336:247-52; PMID:23531411; http://dx.doi. org/10.1016/j.canlet.2013.03.022
14. Seenundun S, Rampalli S, Liu QC, Aziz A, Palii C, Hong S, Blais A, Brand M, Ge K, Dilworth FJ. UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis. EMBO J 2010; 29:1401-11; PMID:20300060; http://dx.doi. org/10.1038/emboj.2010.37
15. Marks H, Kalkan T, Menafra R, Denissov S, Jones K, Hofemeister H, Nichols J, Kranz A, Stewart AF, Smith A, et al. The transcriptional and epigenomic foundations of ground state pluripotency. Cell 2012; 149:590-604; PMID:22541430; http://dx.doi. org/10.1016/j.cell.2012.03.026
16. Habibi E, Brinkman AB, Arand J, Kroeze LI, Kerstens HHD, Matarese F, Lepikhov K, Gut M, Brun-Heath I, Hubner NC, et al. Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells. Cell Stem Cell 2013; 13:360-9; PMID:23850244; http://dx.doi.org/10.1016/j.stem.2013.06.002
17. Hu M, Deng K, Qin Z, Dixon J, Selvaraj S, Fang J, Ren B, Liu JS. Bayesian inference of spatial organizations of chromosomes. PLoS Comput Biol 2013; 9:e1002893; PMID:23382666; http://dx.doi. org/10.1371/journal.pcbi.1002893
18. Selvaraj S, R Dixon J, Bansal V, Ren B. Wholegenome haplotype reconstruction using proximityligation and shotgun sequencing. Nat Biotechnol 2013; 31:1111-8; PMID:24185094; http://dx.doi. org/10.1038/nbt.2728
19. Liang J, Lacroix L, Gamot A, Cuddapah S, Queille S, Lhoumaud P, Lepetit P, Martin P, Vogelmann J, Court F, et al. Chromatin Immunoprecipitation Indirect Peaks Highlight Long-Range Interactions of Insulator Proteins and Pol II Pausing. Mol Cell 2014; Fothcoming; PMID: 24486021; http://dx.doi. org/10.1016/j.molcel.2013.12.0
20. Guetg C, Scheifele F, Rosenthal F, Hottiger MO, Santoro R. Inheritance of silent rDNA chromatin is mediated by PARP1 via noncoding RNA. Mol Cell 2012; 45:790-800; PMID:22405650; http://dx.doi. org/10.1016/j.molcel.2012.01.024
21. Landan G, Cohen NM, Mukamel Z, Bar A, Molchadsky A, Brosh R, Horn-Saban S, Zalcenstein DA, Goldfinger N, Zundelevich A, et al. Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues. Nat Genet 2012; 44:1207-14; PMID:23064413; http://dx.doi.org/10.1038/ ng.2442
22. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D, et al. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 2011; 43:768-75; PMID:21706001; http://dx.doi. org/10.1038/ng.865
23. Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet 2009; 41:246-50; PMID:19151716; http://dx.doi.org/10.1038/ng.297
24. McDonald OG, Wu H, Timp W, Doi A, Feinberg AP. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat Struct Mol Biol 2011; 18:867-74; PMID:21725293; http:// dx.doi.org/10.1038/nsmb.2084
25. Pujadas E, Feinberg AP. Regulated noise in the epigenetic landscape of development and disease. Cell 2012; 148:1123-31; PMID:22424224; http://dx.doi. org/10.1016/j.cell.2012.02.045
26. Timp W, Feinberg AP. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer 2013; 13:497-510; PMID:23760024; http://dx.doi.org/10.1038/ nrc3486
27. Yamashita K, Dai T, Dai Y, Yamamoto F, Perucho M. Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 2003; 4:121-31; PMID:12957287; http://dx.doi.org/10.1016/ S1535-6108(03)00190-9
28. Suzuki K, Suzuki I, Leodolter A, Alonso S, Horiuchi S, Yamashita K, Perucho M. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 2006; 9:199-207; PMID:16530704; http://dx.doi.org/10.1016/j. ccr.2006.02.016
29. Kamiyama H, Suzuki K, Maeda T, Koizumi K, Miyaki Y, Okada S, Kawamura YJ, Samuelsson JK, Alonso S, Konishi F, et al. DNA demethylation in normal colon tissue predicts predisposition to multiple cancers. Oncogene 2012; 31:5029-37; PMID:22310288; http://dx.doi.org/10.1038/onc.2011.652
30. Scherf DB, Sarkisyan N, Jacobsson H, Claus R, Bermejo JL, Peil B, Gu L, Muley T, Meister M, Dienemann H, et al. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4. Oncogene 2013; 32:3329-38; PMID:22945651; http://dx.doi. org/10.1038/onc.2012.344
31. Fernandez AF, Assenov Y, Martin-Subero JI, Balint B, Siebert R, Taniguchi H, Yamamoto H, Hidalgo M, Tan AC, Galm O, et al. A DNA methylation fingerprint of 1628 human samples. Genome Res 2012; 22:407-19; PMID:21613409; http://dx.doi. org/10.1101/gr.119867.110
32. Palii CG, Perez-Iratxeta C, Yao Z, Cao Y, Dai F, Davison J, Atkins H, Allan D, Dilworth FJ, Gentleman R, et al. Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages. EMBO J 2011; 30:494-509; PMID:21179004; http://dx.doi.org/10.1038/ emboj.2010.342
33. Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan WI, Robson SC, Chung CW, Hopf C, Savitski MM, et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 2011; 478:529-33; PMID:21964340; http://dx.doi.org/10.1038/ nature10509
34. Dawson MA, Gudgin EJ, Horton SJ, Giotopoulos G, Meduri E, Robson S, Cannizzaro E, Osaki H, Wiese M, Putwain S, et al. Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia. Leukemia 2013; (Forthcoming); PMID:24220271; http:// dx.doi.org/10.1038/leu.2013.338
35. Wyspianska BS, Bannister AJ, Barbieri I, Nangalia J, Godfrey A, Calero-Nieto FJ, Robson S, Rioja I, Li J, Wiese M, et al. BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms. Leukemia 2014; 28:88-97; PMID:23929215; http://dx.doi. org/10.1038/leu.2013.234
36. Marek M, Kannan S, Hauser A-T, Moraes Mourão M, Caby S, Cura V, Stolfa DA, Schmidtkunz K, Lancelot J, Andrade L, et al. Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni. PLoS Pathog 2013; 9:e1003645; PMID:24086136; http:// dx.doi.org/10.1371/journal.ppat.1003645
37. Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 2011; 305:59-67; PMID:21205967; http://dx.doi. org/10.1001/jama.2010.1919
38. Di Leva G, Garofalo M, Croce CM. MicroRNAs in Cancer. Annu Rev Pathol 2013; 9:287-314; PMID:24079833; http://dx.doi.org/10.1146/ annurev-pathol-012513-104715
39. Iliou MS, da Silva-Diz V, Carmona FJ, Ramalho-Carvalho J, Heyn H, Villanueva A, Muñoz P, Esteller M. Impaired DICER1 function promotes stemness and metastasis in colon cancer. Oncogene 2013; (Forthcoming); PMID:24096488; http://dx.doi. org/10.1038/onc.2013.398
40. Guil S, Soler M, Portela A, Carrère J, Fonalleras E, Gómez A, Villanueva A, Esteller M. Intronic RNAs mediate EZH2 regulation of epigenetic targets. Nat Struct Mol Biol 2012; 19:664-70; PMID:22659877; http://dx.doi.org/10.1038/nsmb.2315
41. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011; 17:330-9; PMID:21386836; http://dx.doi.org/10.1038/ nm.2305
42. Rodriguez-Paredes M, Martinez de Paz A, Simó-Riudalbas L, Sayols S, Moutinho C, Moran S, Villanueva A, Vázquez-Cedeira M, Lazo PA, Carneiro F, et al. Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis. Oncogene 2013; (Forthcoming); PMID:23770855; http://dx.doi.org/10.1038/ onc.2013.239
43. Cho SW, Kim S, Kim JM, Kim JS. Targeted genome engineering in human cells with the Cas9 RNAguided endonuclease. Nat Biotechnol 2013; 31:230-2; PMID:23360966; http://dx.doi.org/10.1038/ nbt.2507
44. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 2013; 153:910-8; PMID:23643243; http://dx.doi. org/10.1016/j.cell.2013.04.025
45. Li Y, Wang H, Muffat J, Cheng AW, Orlando DA, Lovén J, Kwok S-M, Feldman DA, Bateup HS, Gao Q, et al. Global transcriptional and translational repression in human-embryonic-stem-cellderived Rett syndrome neurons. Cell Stem Cell 2013; 13:446-58; PMID:24094325; http://dx.doi. org/10.1016/j.stem.2013.09.001
46. Bird AP, Wolffe AP. Methylation-induced repression--belts, braces, and chromatin. Cell 1999; 99:451-4; PMID:10589672; http://dx.doi.org/10.1016/ S0092-8674(00)81532-9
47. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr., Kinzler KW. Cancer genome landscapes. Science 2013; 339:1546-58; PMID:23539594; http://dx.doi.org/10.1126/science.1235122
48. Allfrey VG, Faulkner R, Mirsky AE. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci U S A 1964; 51:786-94; PMID:14172992; http://dx.doi. org/10.1073/pnas.51.5.786
49. Christophorou MA, Castelo-Branco G, Halley-Stott RP, Oliveira CS, Loos R, Radzisheuskaya A, Mowen KA, Bertone P, Silva JC, Zernicka-Goetz M, et al. Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature 2014; PMID:24463520; http://dx.doi.org/10.1038/ nature12942